Merck & Co. will help make rival Johnson & Johnson’s Covid-19 vaccine in order to boost the slower-than-promised production of the one-dose shot, U.S. President Joe Biden said on March 2.
A judge in Hawaii ordered Bristol-Myers Squibb Co. and Sanofi SA to pay more than $834 million to the state for failing to warn non-white patients properly of health risks from the blood thinner Plavix.
In a long-running court battle over PCSK9 antibodies, Amgen lost the company’s bid to uphold patent claims for the cholesterol drug Repatha against rival drug Praluent, developed by Sanofi and Regeneron.
The Biden administration is exploring every option for increasing manufacturing of Johnson & Johnson’s Covid-19 vaccine, which is under regulatory review, and said on Feb. 5 that currently expected levels of early doses were less than hoped.
Bayer AG struck a $2 billion deal to resolve future legal claims that the German company widely used weedkiller Roundup causes cancer.
A U.S. judge granted a Reuters request to unseal Merck & Co. documents produced in lawsuits related to the company’s anti-baldness treatment Propecia, finding that the public’s right to access outweighed the drug maker’s arguments for keeping the information secret.
Hours after being sworn in as the 46th President of the United States, Joe Biden signed 10 executive orders aimed at combating the ongoing Covid-19 crisis.
The U.S. Supreme Court rejected Merck & Co. Inc.’s bid to revive a $2.54 billion jury verdict the company won against rival drugmaker Gilead Sciences Inc. for infringing a patent in a dispute over a blockbuster hepatitis C treatment.
President-elect Joe Biden made his selections for two key public health positions, sources said, as he prepares to take office in January while the coronavirus pandemic rages to new levels across the United States.
The U.S. Supreme Court agreed to hear a bid by President Donald Trump’s administration to revive pilot programs adopted by the states of Arkansas and New Hampshire that allow work requirements to be imposed on people who receive healthcare under the Medicaid program for the poor.
